28.22

14.97% -4.97

Pre-market: 28.50 0.28 +0.99%

Arrivent Biopharma Inc (AVBP)

Overview News Price History Discussions Forecast

Arrivent Biopharma Inc stock is traded at $28.22, with a volume of 924.18K. It is down -14.97% in the last 24 hours and down -11.09% over the past month. ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on advancing its lead product candidate, firmonertinib, for the treatment of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), and developing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates such as ARR-217 (MRG007), with an initial focus on solid tumors.

Previous Close:

$33.19

Open:

$33.41

24h Volume:

924.18K

Relative Volume:

1.68

Market Cap:

$1.31B

Revenue:

Net Income/Loss:

$-166.31M

P/E Ratio:

-6.3271

EPS:

-4.4602

Net Cash Flow:

$-160.59M

1W Performance:

-16.11%

1M Performance:

-11.09%

6M Performance:

+26.77%

1Y Performance:

+27.98%

1-Day Range:

$28.01

$33.99

1-Week Range:

$28.01

$33.99

52-Week Range:

$16.10

$35.83

Arrivent Biopharma Inc Stock (AVBP) Company Profile

Name

Arrivent Biopharma Inc

Sector

Healthcare (1089)

Industry

Biotechnology (603)

Phone

240-780-6356

Address

18 CAMPUS BLVD., NEWTOWN SQUARE

Employee

Twitter

Next Earnings Date

2026-08-10

Latest SEC Filings

AVBP's Discussions on Twitter

Compare AVBP vs VRTX, REGN, ARGX, RVMD, ALNY

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AVBP Arrivent Biopharma Inc	28.22	1.31B	0	-166.31M	-160.59M	-4.4602
VRTX Vertex Pharmaceuticals Inc	480.50	121.95B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	672.15	70.47B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	846.19	52.94B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	180.39	38.35B	742.00K	-1.37B	-1.07B	-7.0731
ALNY Alnylam Pharmaceuticals Inc	272.67	36.40B	4.29B	577.22M	641.34M	4.2086

Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-12-26	Resumed	BTIG Research	Buy
Dec-10-25	Initiated	BTIG Research	Buy
Nov-25-25	Initiated	Truist	Buy
Jul-10-25	Resumed	Goldman	Buy
Mar-20-25	Initiated	B. Riley Securities	Buy
Mar-10-25	Initiated	Guggenheim	Buy
Jul-22-24	Initiated	Oppenheimer	Outperform
Apr-30-24	Initiated	H.C. Wainwright	Buy
Feb-20-24	Initiated	Citigroup	Buy
Feb-20-24	Initiated	Goldman	Buy
Feb-20-24	Initiated	Jefferies	Buy

View All

Arrivent Biopharma Inc Stock (AVBP) Latest News

Jul 16, 2026

ArriVent BioPharma Q1 2026 Earnings: EPS Miss Reflects Increased R&D Spending; Shares Edge HigherCEO Earnings Statement - dars.gov.et

Jul 16, 2026

Jul 15, 2026

LifeSci Capital Maintains ArriVent BioPharma(AVBP.US) With Buy Rating, Maintains Target Price $42 - Moomoo

Jul 15, 2026

BTIG Maintains ArriVent BioPharma(AVBP.US) With Buy Rating, Maintains Target Price $42 - Moomoo

Jul 15, 2026

ArriVent’s Firmonertinib Seen as Differentiated EGFR Inhibitor Ahead of FURVENT Readout; Buy Rating Reiterated with Unchanged $42 Price Target - TipRanks

Jul 15, 2026

Jul 12, 2026

(AVBP) Volatility Zones as Tactical Triggers - Stock Traders Daily

Jul 12, 2026

AVBP Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Jul 12, 2026

Jul 11, 2026

AVBP Q1 2026 Earnings: EPS Miss Highlights Development Stage ChallengesEPS Growth Rate - DonanımHaber

Jul 11, 2026

Jul 07, 2026

ArriVent BioPharma (AVBP) Edges Lower Amid Consolidation Near Key LevelsPCR Divergence - dars.gov.et

Jul 07, 2026

JonesTrading Maintains ArriVent BioPharma(AVBP.US) With Buy Rating, Maintains Target Price $45 - Moomoo

Jul 07, 2026

Jul 06, 2026

ArriVent’s Emerging CDH17-Targeted ADC Pipeline Supports Maintained Buy Rating and $45 Price Target - TipRanks

Jul 06, 2026

Jul 01, 2026

Enterprise value to revenue forward of ArriVent BioPharma, Inc. – NASDAQ:AVBP - TradingView

Jun 28, 2026

Price to book forward of ArriVent BioPharma, Inc. – BOATS:AVBP - TradingView

Jun 28, 2026

Price to earnings forward of ArriVent BioPharma, Inc. – NASDAQ:AVBP - TradingView

Jun 28, 2026

Price to earnings forward of ArriVent BioPharma, Inc. – BOATS:AVBP - TradingView

Jun 28, 2026

ArriVent BioPharma (AVBP) Posts Modest Gain at $34.0, Hovers Near ResistanceFundamentals - dars.gov.et

Jun 28, 2026

Jun 27, 2026

Price to sales forward of ArriVent BioPharma, Inc. – NASDAQ:AVBP - TradingView

Jun 27, 2026

AVBP Q1 2026 Earnings: EPS Misses Estimates as Biotech Focuses on Clinical MilestonesCore Business Growth - dars.gov.et

Jun 27, 2026

Jun 25, 2026

AVBP 260717 5.00P (AVBP260717P5000) Stock Options Chain | Quotes & News - Moomoo

Jun 25, 2026

ArriVent BioPharma, Inc. Actuals & Estimates (NASDAQ:AVBP) - TradingView

Jun 25, 2026

AVBP Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 24, 2026